Summary
A comparative pharmacokinetic study was performed with two types of suppository each containing 20 mg piroxicam. The bioavailability of piroxicam was studied in 24 healthy volunteers in a double blind, randomised, cross over study.
No significant difference was found in the pharmacokinetic parameters [AUC(0–72 h), AUC, Cmax, t1/2β calculated from plasma concentration time curves, indicating that the two preparations were bioequivalent.
References
Lombardino JG, Wiseman EH, Chiaini I (1973) Potent antiinflammatory N-heterocyclic 3-carboxamides of 4-hydroxy-2-methyl-2H-1,2-benzothiazine 1,1-dioxide. J Med Chem 16: 493–496
Wiseman EH, Chang YH, Lombardino JG (1976) Piroxicam, a novel anti-inflammatory agent. Arzneim/Forsch 26: 1300–1303
Otterness IG, Wiseman EH, Gans DJ (1977) Piroxicam. Agents Actions 9: 177–182
Brogden RN, Pinder RM, Speight TM (1977) Piroxicam; a review of its pharmacological properties and therapeutic efficacy. Drugs 22: 165–187
Hobbs DC (1983) Pharmacokinetics of piroxicam in man. Eur J Rheum Inflam 6: 46–55
Schiantarelli P, Acerbi D, Bovis G (1981) Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam and rodents and in man. Arzneim Forsch 31: 92–98
Skreblin M, Alebic-Kolbah T, Hofman H (1987) Piroxicam bioavailability by rectal application of Felden and Luber, and oral application of Lubor. Acta Pharm Jugosl 37: 361–369
Hobbs DC, Twomey TM (1979) Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol 19: 270–281
Macek J, Vacha J (1987) Rapid and sensitive method for determination of piroxicam in human plasma by high-performance liquid chromatography. J Chromatogr 420: 445–449
Acerbi D, Dacco L, Palummeri E (1983) Pharmacokinetic study of piroxicam after p. o. and rectal administration. Boll Chim Farm 122 [Suppl] 19–27
Ishizaki T, Nomura T, Abe T (1979) Pharmacokinetics of piroxicam, a new nonsteroidal, anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm 7: 369–381
Rogers HJ, Savitshy IP, Glenn B (1981) Kinetics of single doses of fenbufen in patients with renal sufficience. Clin Pharmacol Ther 29: 74–80
Brogden RN, Heel RC, Speight TM, Avery GS (1981) Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain. Drugs 21: 1–22
Lombardino JG, Wiseman EH, Otterness IG (1975) Acidic antiinflammatory agents -correlations of some physical, pharmacological and clinical data. Arzneim Forsch 25: 1629–1634
Twomey TM, Hobbs DC (1978) Biotransformation of piroxicam by man. Fed Proc 37: 271–275
Twomey TM, Bartolucci SE, Hobbs DC (1980) Analysis of piroxicam in plasma by high-performance liquid chromatography. J Chromatogr 183: 104–108
Benkő-Márkus S, Grézal Gy, Nagy É, Klebovich I (1991) Comparative pharmacokinetic and bioequivalence studies. (in Hungarian) Gyógyszerészet 35: 479–481
Schuirmann DJ (1987) A comparison of the two one-sided test procedure and the power approach for assesing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15: 657–680
Westlake WJ (1976) Symmetrical confidence intervals for bioequivalence trials. Biometrics 32: 741–744
Westlake WJ (1978) Table to facilitate determination of symmetrical confidence intervals in bioavailability trials with Westlake's method. Eur J Drug Metab Pharmacokinet 2: 129–132
Hauck WW, Anderson S (1984) A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. J Pharmacokinet Biopharm 12: 83–91
Svåb J (1981) Biometrical methods in the research. Mezőgazdasági Kiadó, Budapest (in Hungarian)
Pabst G, Jaeger H (1990) Review of methods and criteria for evaluation of bioequivalence studies. Eur J Clin Pharmacol 38: 5–10
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benkö, S., Grézal, G., Nagy, É. et al. Comparative bioavailability of two different rectal preparations of piroxicam in man. Eur J Clin Pharmacol 43, 315–317 (1992). https://doi.org/10.1007/BF02333031
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02333031